Judith A Aberg
Affiliation: New York University School of Medicine
- Lipid management in patients who have HIV and are receiving HIV therapyJudith A Aberg
Bellevue Hospital Center, AIDS Clinical Trials Unit, New York University School of Medicine, 550 First Avenue, BCD 5 Room 558, NY 10016, USA
Endocrinol Metab Clin North Am 38:207-22. 2009..Evidence for these two strategies is discussed...
- Cardiovascular complications in HIV management: past, present, and futureJudith A Aberg
AIDS Clinical Trials Unit, Bellevue Hospital Center, New York University School of Medicine, New York, NY 10016, USA
J Acquir Immune Defic Syndr 50:54-64. 2009..These benefits of antiretroviral therapy have been demonstrated in studies comparing the superior efficacy of continuous vs. intermittent HAART...
- Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of AmericaJudith A Aberg
New York University School of Medicine, Bellevue Hospital Center, New York, USA
Clin Infect Dis 49:651-81. 2009..HIV-infected persons should be managed and monitored for all relevant age- and gender-specific health problems. New information based on publications from the period 2003-2008 has been incorporated into this document...
- Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108Judith A Aberg
New York University, New York, New York, USA
AIDS 20:725-9. 2006..Nelfinavir, an HIV protease inhibitor with numerous drug-drug interactions, is associated with dyslipidemia. Pravastatin is the preferred statin prescribed for HIV-associated dyslipidemia...
- Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of AmericaJudith A Aberg
AIDS Clinical Trials Unit, Bellevue Hospital Center, New York University, New York 10016, USA
Clin Infect Dis 39:609-29. 2004
- Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockersMarshall J Glesby
Weill Medical College of Cornell University, New York, NY 10021, USA
Clin Pharmacol Ther 78:143-53. 2005..We evaluated potential bidirectional pharmacokinetic interactions between calcium channel blockers and coadministered indinavir and ritonavir...
- A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087Judith A Aberg
AIDS Clinical Trials Unit, Bellevue Hospital Center, New York University, New York, New York 10016, USA
AIDS Res Hum Retroviruses 21:757-67. 2005..Combination therapy with fenofibrate and pravastatin for HIV-related dyslipidemia provides substantial improvements in lipid parameters and appears safe, but is unlikely to achieve all NCEP targets for lipid levels...
- Risk factors for tuberculin skin test conversion among HIV-infected patients in New York CitySaumil Doshi
Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, 550 First Avenue, BCD, Room 649, New York, NY 10016, USA
Int J Infect Dis 16:e518-21. 2012..We assessed the incidence of and risk factors for tuberculin skin test (TST) conversion among HIV-infected adults at a New York City clinic...
- Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapyDemetre Daskalakis
Division of Infectious Disease and Immunology, Department of Medicine, New York University School of Medicine/Bellevue Hospital, New York, NY, USA
MedGenMed 7:9. 2005
- Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapyJudith A Aberg
Department of Medicine, Washington University School of Medicine, AIDS Clinical Trials Unit, St Louis, MO, 63108, USA
Clin Infect Dis 35:E8-E13. 2002..The low rate of these unusual MAC infections does not warrant continuation of primary or secondary prophylaxis after presumed immune reconstitution...
- Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New YorkCandice K Kwan
Bellevue Hospital Center, New York City Health and Hospital Corporation, New York, USA
AIDS Res Hum Retroviruses 28:1025-32. 2012..In HIV-infected patients with severe vitamin D deficiency or hyperparathyroidism, screening for osteomalacia and osteopenia may be warranted...
- Coronary heart disease in people infected with HIVCarlos D Malvestutto
New York University Langone Medical Center, New York, USA
Cleve Clin J Med 77:547-56. 2010..As this population ages, cardiovascular disease is becoming an important cause of morbidity and death. The authors of this review discuss the magnitude and likely mechanisms of the risk and strategies for managing it...
- Drug-drug interactions with newer antiretroviral agentsJudith A Aberg
New York University School of Medicine and Bellevue Hospital Center, New York, NY, USA
Top HIV Med 16:146-50. 2008....
- Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individualsDonald Chen
New York University, Department of Medicine, Division of Infectious Disease, AIDS Clinical Trials Unit, Bellevue C and D Building, Room 558, 550 First Avenue, New York, NY 10016 6481, USA
Expert Rev Anti Infect Ther 5:921-8. 2007..To date, human trials suggest that pafuramidine is well tolerated overall and has clinical activity against Pneumocystis pneumonia. In this article, we review the available data for the use of pafuramidine in Pneumocystis pneumonia...
- Neuropsychiatric complications of antiretroviral therapyMichelle S Cespedes
Division of Infectious Disease, Department of Medicine, New York University School of Medicine, New York, New York 10016, USA
Drug Saf 29:865-74. 2006..Our intent is to present practitioners with data that can be used in a practical way to both educate and improve outcomes in the HIV-infected patient population...
- Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trialScott M Hammer
Division of Infectious Diseases, Department of Medicien, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA
JAMA 288:169-80. 2002..Management of antiretroviral treatment failure in patients receiving protease inhibitor (PI)-containing regimens is a therapeutic challenge...
- Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individualsBenjamin J Eckhardt
Bellevue Hospital Center, NY City Health and Hospital Corporation, New York, USA
AIDS Patient Care STDS 26:197-201. 2012..Current antiretroviral (ART) use has significant and variable influence on the relationship between HbA(1c) and FBG. The use of HbA(1c) in conjunction with FBG may be the best modality to screen for diabetes...
- A tale of two fungi in a person with HIVJason Faulhaber
Division of Infectious Diseases and Immunology, New York University School of Medicine, New York, NY, USA
MedGenMed 8:2. 2006
- Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York CitySapna A Mehta
Division of Infectious Diseases, Department of Medicine, NewYork University School of Medicine, New York, New York, USA
Sex Transm Infect 87:344-8. 2011..To understand the factors associated with knowledge of non-occupational post-exposure prophylaxis (nPEP) and pre-exposure prophylaxis (PrEP), bathhouse patrons in New York City (NYC) were surveyed...
- Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsChristian A Engell
Department of Medicine, Division of Infectious Diseases and Immunology, New York University School of Medicine at Bellevue Hospital Center, New York, NY 10016, USA
ISRN Gastroenterol 2011:405390. 2011..There was a significantly greater proportion of naïve patients with suppressed HBV DNA at 24 months. Our results support using initial dual therapy in those with HIV/HBV coinfection...
- A case of nocardia osteomyelits--is HIV to blame?Judith A Aberg
Washington University, AIDS Clinical Trials Unit, St Louis, USA
AIDS Read 12:77. 2002